Lonza plans a new factory in Bend, Oregon to expand US spray-drying capacity for complex drug formulations.
Lonza is building a new factory in the United States
Keystone-SDA
Lonza is set to begin construction of a production site dedicated to spray-drying in the United States. The plant, which will be built in Bend, Oregon, is expected to be operational in 2029 and to create more than 80 jobs.
Generated with artificial intelligence.
This content was published on
Swiss CDMOS making moves: Lonza bets on new US facility, CordenPharma scales injectables with €80M
Sandoz unveils plan for biosimilar expansion and new $300M factory in Slovenia
Biosimilars: Sandoz setzt sich ehrgeizige Wachstumsziele
Sandoz pretende mais que dobrar vendas até 2035
Sandoz sets sights on 100 biosimilars in new 2040 strategy, with $300M facility build
Lonza is expanding its collaboration with an American biopharmaceutical company, the identity of which has not been disclosed.
In a series of moves by Switzerland-headquartered CDMOs this week, manufacturing powerhouse Lonza is doubling down on its US…
Lonza said it wants to own the commercial market for antibody-drug conjugates, with a new manufacturing site set to come online…
Contract manufacturing powerhouse Lonza is growing in more ways than one. | Contract manufacturing powerhouse Lonza is growing in…
Der Pharmahersteller Lonza sieht sich dank seinem internationalen Produktionsnetz im Vorteil. Im neuen grossen Werk in…
Eight months after more than doubling down on its construction of a $2 billion drug manufacturing facility in Holly Springs,…
